Priorities and uncertainties of administering chemotherapy in a pregnant woman with newly diagnosed colorectal cancer

Journal of Oncology Pharmacy Practice

Volumn 15, Issue 1, 2009, Pages 5-8

  Kanate, Abraham S ^a   Auber, Miklos L ^a   Higa, Gerald M ^a,b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Abortion; Cancer in pregnancy; Chemotherapy; Colorectal cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; LANSOPRAZOLE; LEVOTHYROXINE; OXALIPLATIN; SEROTONIN 3 ANTAGONIST;

ADULT; ARTICLE; ASPIRATION BIOPSY; CASE REPORT; CESAREAN SECTION; COLON BIOPSY; COLONOSCOPY; COLORECTAL CANCER; CONTINUOUS INFUSION; ECHOGRAPHY; FEMALE; FETAL WELL BEING; GASTROESOPHAGEAL REFLUX; GESTATION PERIOD; HUMAN; HYPOTHYROIDISM; INFANT; LUNG METASTASIS; LUNG NODULE; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTETRIC CARE; PATIENT COUNSELING; PREMATURITY; PRIORITY JOURNAL; THORAX PAIN;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; TREATMENT OUTCOME;

EID: 61749094909     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155208094101     Document Type: Article

References (14)

1. Jemal A., Siegel R., Ward E., Taylor M., Xu J., Thun MJ Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Bernstein MA, Madoff RD, Caushaj PF Colon and rectal cancer in pregnancy. Dis Colon Rectum 1993; 36: 172-78.
3. Sipek A., Gregor V., Velebil P., Horacek J., Masatova D., Svetnicova K. Incidence of congenital defects in the children of mothers who used medications in the first trimester of pregnancy in the Czech Republick 1996-2001. Ceska Gynekol 2003; 68: 401-19.
4. Paskulin GA, Gazzola Zen PR, de Camargo Pinto LL, Rosa R., Graziadio C. Combined chemotherapy and teratogenicity. Birth Defects Res A Clin Mol Teratol 2005; 73: 634-37.
5. Hahn KM, Johnson PH, Gordon et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006; 107: 1219-26.
6. Berry DL, Theriault RL, Holmes FA et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999; 17: 855-61.
7. de Gramont A., Figer A., Seymour M. et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-47.
8. Saltz LB, Douillard JY, Pirotta N. et al. Irinotecan plus fluorouracil/ leucovorin for metastatic colorectal cancer: A new survival standard. Oncologist 2001; 6: 81-91.
9. Cunningham D., Humblet Y., Siena S. et al. Cetuximb monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004; 351: 337-47.
10. Hurwitz H., Fehrenbacher T., Cartwright J. et al. Bevacizumab plus irinotecan fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-42.
11. Cappell MS Colon cancer during pregnancy: The gastroenterologist's perspective. Gastroenterol Clin North Am 1998; 27: 225-56.
12. JAOA • Vol 101 • No 12 • Supplement to December 2001 Part 2 Osias et al • Colorectal cancer in women: An equal opportunity Disease.
13. Saif MW Management of colorectal cancer in pregnancy: A multimodality approach. Clin Colorectal Cancer 2005; 5: 247-56.
14. Vitoratos N., Salamalekis E., Makrakis E., Creatsas G. Sigmoid colon cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 2002; 104: 70-72.